KENDALL SACHARCZYK: Open Payments
NPI 1427603323 · GERMANTOWN, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$647 in 33 payments from 16 companies in 2025. Trend: 2023 $196 · 2024 $679 · 2025 $647
Food & beverage: $647
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 6 | $145 |
| ABBVIE INC. | 4 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $53 |
| C2N Diagnostics, LLC | 2 | $49 |
| PFIZER INC. | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Amgen Inc. | 2 | $34 |
| Boston Scientific Corporation | 1 | $32 |
| Exact Sciences Corporation | 2 | $29 |
| Seqirus USA Inc | 1 | $26 |
Products named: UBRELVY, Wegovy, Kerendia, PRECIVITYAD2, NURTEC ODT, Rybelsus, Ozempic, OTEZLA.
Industry payments across TN — which companies pay providers there.
